v3.26.1
Commitments and Contingencies - Narrative (Details)
$ in Millions
 12 Months Ended
Oct. 11, 2023
ft²
Mar. 31, 2023
USD ($)
ft²
extensionTerm
Dec. 31, 2025
USD ($)
Feb. 28, 2026
USD ($)
Jan. 31, 2026
USD ($)
Lessee, Lease, Description [Line Items]          
Purchase obligation     $ 19.7    
Purchase obligation, to be paid within one year     16.1    
Purchase obligation, to be paid, over one to three years     3.6    
Lease term (in years)   10 years      
Area of real estate property | ft²   18,922      
Rent expense   $ 1.6      
Rent expense, year 10   1.9      
Letter of credit outstanding   $ 0.7      
Number of options to extend | extensionTerm   1      
Lease, renewal term (in years)   5 years      
Period of sublease agreement (in years) 5 years        
Number of square feet to sublease | ft² 4,242        
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Lessee, Lease, Description [Line Items]          
Expenses reflecting development milestone payments     12.2    
Maximum aggregate development and regulatory milestone payments     3.6    
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Subsequent Event          
Lessee, Lease, Description [Line Items]          
Maximum aggregate development and regulatory milestone payments       $ 3.0 $ 1.8
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Orexia          
Lessee, Lease, Description [Line Items]          
Maximum aggregate development milestone payments     4.3    
Maximum aggregate commercial milestone payments     $ 15.0    
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Nxera Pharma UK Limited          
Lessee, Lease, Description [Line Items]          
Period after contractual agreement ends (in years)     3 years    
Period after first commercial sale (in years)     10 years